We have shown that InuA exerts robust inhibitory effects on the proliferation, migration, and invasion of prostate cancer cells, as well as on the protein expression of MDM2 and MDMX, in a p53- and androgen-independent manner. Here, MDM4 is linked to prostate carcinoma.